YMC 5 Year Vision
YMC’s Corporate Vision was recently articulated by YMC President Ryuji Yamamura, and published in an issue of Newsweek International.
In the article, Mr. Yamamura points out that, “… the greatest strength of YMC’s business model is that we are uniquely positioned to offer our customers a platform that allows them to determine which packing materials, which devices/system/instruments, and which methods can be applied to achieve maximum production efficiency.”
The article can be found here.
Previous Article
Large scale production of peptide program announced Related Posts
June 18, 2026
Happy Retirement, John!
Today, we are celebrating John Heffernan, who is officially stepping into retirement after 16 years with YMC America.
John’s journey with us actually began back when we were known as Integrated Process Technologies, long before we transitioned to YMC America. Over the years, John has worn many hats, from Project Manager to Estimating Manager, Engineering Manager, and ultimately Director of Business Development.
June 2, 2026
Chromatography of Biotherapeuticals – Analyzing and Purifying Peptides and Oligonucleotides
This webinar will highlight how advanced ultra-high-performance liquid chromatography (UHPLC) strategies, carefully selected stationary phases, and bioinert hardware can significantly improve the analysis and purification of peptides and oligonucleotides.
May 21, 2026
Breaking Down mRNA Capping Efficiency with High-Resolution IP-RP LC
Evaluating 5' capping efficiency is a critical quality attribute in therapeutic mRNA manufacturing, directly impacting translation efficiency and transcript stability. However, separating structurally similar capped, partially capped, and uncapped species differing by just a single nucleotide remains a significant chromatographic challenge.
